Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-08-18 4:17 pm Purchase | 13G | EYEGATE PHARMACEUTICALS INC CO EYEG | INTRACOASTAL CAPITAL LLC | 460,978 3.5% | 460,978 (New Position) | View |
| 2021-08-17 4:45 pm Purchase | 13G | EYEGATE PHARMACEUTICALS INC CO EYEG | Lind Global Macro Fund LP | 1,302,933 9.9% | 1,302,933 (New Position) | View |
| 2021-08-13 4:01 pm Unchanged | 13G | EYEGATE PHARMACEUTICALS INC CO EYEG | ARMISTICE CAPITAL LLC | 2,916,101 19.8% | 0 (Unchanged) | View |
| 2021-08-03 5:04 pm Sale | 13D | EYEGATE PHARMACEUTICALS INC CO EYEG | ARMISTICE CAPITAL LLC | 2,916,101 28.9% | -1,883,000 (-39.24%) | View |
| 2021-02-09 2:53 pm Sale | 13G | EYEGATE PHARMACEUTICALS INC CO EYEG | Hudson Bay Capital Management LP | 0 0% | -328,192 (Position Closed) | View |
| 2021-01-12 5:08 pm Purchase | 13D | EYEGATE PHARMACEUTICALS INC CO EYEG | ARMISTICE CAPITAL LLC | 4,799,101 56.2% | 1,554,101 (+47.89%) | View |
| 2020-02-05 2:21 pm Purchase | 13G | EYEGATE PHARMACEUTICALS INC CO EYEG | Hudson Bay Capital Management LP | 328,192 8.11% | 328,192 (New Position) | View |
| 2020-01-27 4:57 pm Sale | 13G | EYEGATE PHARMACEUTICALS INC CO EYEG | Lau Jonathan | 15,798 0.43% | -3,793,582 (-99.59%) | View |
| 2020-01-15 4:46 pm Unchanged | 13D | EYEGATE PHARMACEUTICALS INC CO EYEG | ARMISTICE CAPITAL LLC | 3,245,000 54.1% | 0 (Unchanged) | View |
| 2020-01-10 4:07 pm Unchanged | 13D | EYEGATE PHARMACEUTICALS INC CO EYEG | ARMISTICE CAPITAL LLC | 3,245,000 54.1% | 0 (Unchanged) | View |
| 2019-10-18 4:36 pm Purchase | 13D | EYEGATE PHARMACEUTICALS INC CO EYEG | ARMISTICE CAPITAL LLC | 3,245,000 63.8% | 852,500 (+35.63%) | View |
| 2019-10-01 7:46 pm Purchase | 13D | EYEGATE PHARMACEUTICALS INC CO EYEG | ARMISTICE CAPITAL LLC | 2,392,500 56.4% | 2,392,500 (New Position) | View |